According to the latest research, Lu et al. extended the traditional view that apoptosis is the only death pathway for molecular targeted therapies, and established a potential clinical correlation between GSDME expression and the pyroptotic process of lung cancer. The gene discussed is GSDME; the disease is lung cancer.